These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8006647)

  • 41. Discontinuation of phenytoin, carbamazepine, and valproate in patients with active epilepsy.
    Duncan JS; Shorvon SD; Trimble MR
    Epilepsia; 1990; 31(3):324-33. PubMed ID: 2111768
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [A practical study of the efficacy of a delayed-action preparation of carbamazepine (Tegretol CR 400) in the treatment of patients with partial epilepsy ].
    Vojvodić NM; Sokić DV; Janković SM; Lević Z
    Srp Arh Celok Lek; 2002; 130(1-2):19-26. PubMed ID: 12073283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Withdrawal of anticonvulsant drugs in patients free of seizures for two years. A prospective study.
    Callaghan N; Garrett A; Goggin T
    N Engl J Med; 1988 Apr; 318(15):942-6. PubMed ID: 3127710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Valproate in the treatment of partial epilepsies.
    Chadwick D
    Epilepsia; 1994; 35 Suppl 5():S96-8. PubMed ID: 8039481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomised controlled monotherapy trials: which comparators to use?
    Beghi E
    Epileptic Disord; 2012 Sep; 14(3):235-41. PubMed ID: 22940281
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sodium valproate in the treatment of resistant epilepsy.
    Hassan MN; Laljee HC; Parsonage MJ
    Acta Neurol Scand; 1976 Sep; 54(3):209-218. PubMed ID: 822682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial.
    Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M
    Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy and safety of antiepileptic therapy in children (a comparative analysis of valproates and barbiturates)].
    Pylaeva OA; Petrukhin AS; Voronkova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):61-5. PubMed ID: 15554145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of carbamazepine and valproate on brainstem auditory evoked potentials in epileptic children.
    Yuksel A; Senocak D; Sozuer D; Keskin G; Dirican A; Cenani A; Yalcin E
    Childs Nerv Syst; 1995 Aug; 11(8):474-7. PubMed ID: 7585685
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study.
    Zeng QY; Fan TT; Zhu P; He RQ; Bao YX; Zheng RY; Xu HQ
    PLoS One; 2015; 10(7):e0131566. PubMed ID: 26147937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monotherapy with valproate in primary generalized epilepsies.
    Bourgeois B; Beaumanoir A; Blajev B; de la Cruz N; Despland PA; Egli M; Geudelin B; Kaspar U; Ketz E; Kronauer C
    Epilepsia; 1987; 28 Suppl 2():S8-11. PubMed ID: 3121293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid hormone levels in children receiving carbamazepine or valproate.
    Aggarwal A; Rastogi N; Mittal H; Chillar N; Patil R
    Pediatr Neurol; 2011 Sep; 45(3):159-62. PubMed ID: 21824562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative efficacy of antiepileptic drugs for patients with generalized epileptic seizures: systematic review and network meta-analyses.
    Campos MSA; Ayres LR; Morelo MRS; Carizio FAM; Pereira LRL
    Int J Clin Pharm; 2018 Jun; 40(3):589-598. PubMed ID: 29744790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The problem of non-superiority: what do we know after KOMET?
    Sönnichsen AC
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1067. PubMed ID: 23123641
    [No Abstract]   [Full Text] [Related]  

  • 55. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Favorable outcome of epileptic blindness in children.
    Shahar E; Barak S
    J Child Neurol; 2003 Jan; 18(1):12-6. PubMed ID: 12661932
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in adult patients with epilepsy resistant carbamazepine and valproate].
    Jóźwiak S; Niedzielska K; Mańko E; Terczyński A
    Neurol Neurochir Pol; 2000; 34(4):673-89. PubMed ID: 11105300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Valproate monotherapy in partial seizures.
    Penry JK; Dean JC
    Am J Med; 1988 Jan; 84(1A):14-6. PubMed ID: 3146219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxcarbazepine versus phenytoin monotherapy for epilepsy.
    Muller M; Marson AG; Williamson PR
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.